EUVIMEDEUVIMED entdecken
Crossref

Intraprocedural Yield Estimation Using Interim Product CD34 + Concentration Improves the Prediction Accuracy in Allogeneic Peripheral Blood Stem Cell Harvest

Kazuya Okada iD, Mayumi Murata, Yoshihiro Yabuta, Ryoko Ishida, Mina Higuchi, Fumie Tasaka, Tomoko Imanaka, Junko Nakamura, Ryosuke Takaya, Takashi Nagayama, Hiroyuki Muranushi iD, Takayuki Sato und 3 weitere

Therapeutic Apheresis and Dialysis · 2026-12 · 30 (6) · 960-970

DOI: 10.1002/1744-9987.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 09.07.2026. Verfasst von Kazuya Okada und 14 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan. Hauptthemen laut MEDLINE: Antigens, CD34, Peripheral Blood Stem Cells, Blood Component Removal, Peripheral Blood Stem Cell Transplantation. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Accurate prediction of final CD34+ cell yield may reduce donor burden by limiting processed blood volume (PBV) during allogeneic peripheral blood stem cell harvest.

Methods

We retrospectively analyzed 86 procedures in 81 healthy donors. Predictions based on preprocedure peripheral blood CD34+ cell concentration and interim collection‐product CD34+ cell concentration, measured when PBV reached approximately 50 mL/kg, were compared. Absolute prediction error was compared within procedures. We also evaluated CD34 percent change (CD34% change), defined as the relative change in product CD34+ cell concentration from interim sampling to the final product, and factors associated with CD34% change ≤ −10%.

Results

Interim‐CD34‐based prediction showed a smaller absolute prediction error than Pre‐CD34‐based prediction ( p = 0.034). Median CD34% change was −3.6%, and CD34% change ≤ −10% occurred in 27.9% of procedures. Higher preprocedure platelet count was associated with this decrease.

Conclusion

Interim‐CD34‐based prediction improved yield estimation and may enable PBV optimization during apheresis while maintaining target doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CD34Peripheral Blood Stem CellsBlood Component RemovalPeripheral Blood Stem Cell TransplantationHumansRetrospective StudiesFemaleMaleAdultMiddle AgedTransplantation, HomologousBlood Volume

Stichwörter der Autor:innen

CD34allogeneicapheresisperipheral blood stem cell harvestprediction

Substanzen

Antigens, CD34

Autor:innen und Institutionen

  • Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan.
  • Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Department of Clinical Laboratory, Kurashiki Central Hospital, Kurashiki, Japan.

ORCID-Profile: Kazuya Okada, Hiroyuki Muranushi, Yasunori Ueda

Zitieren

APA

Okada, K., Murata, M., Yabuta, Y., Ishida, R., Higuchi, M., Tasaka, F., Imanaka, T., Nakamura, J., Takaya, R., Nagayama, T., Muranushi, H., Sato, T., Maeda, T., Onishi, T., & Ueda, Y. (2026). Intraprocedural Yield Estimation Using Interim Product CD34 + Concentration Improves the Prediction Accuracy in Allogeneic Peripheral Blood Stem Cell Harvest. Therapeutic Apheresis and Dialysis, 30(6), 960-970. https://doi.org/10.1002/1744-9987.70189

Vancouver

Okada K, Murata M, Yabuta Y, Ishida R, Higuchi M, Tasaka F, et al. Intraprocedural Yield Estimation Using Interim Product CD34 + Concentration Improves the Prediction Accuracy in Allogeneic Peripheral Blood Stem Cell Harvest. Therapeutic Apheresis and Dialysis. 2026;30(6):960-970. doi:10.1002/1744-9987.70189

BibTeX
@article{Okada2026,
  author = {Okada, Kazuya and Murata, Mayumi and Yabuta, Yoshihiro and Ishida, Ryoko and Higuchi, Mina and Tasaka, Fumie and Imanaka, Tomoko and Nakamura, Junko and Takaya, Ryosuke and Nagayama, Takashi and Muranushi, Hiroyuki and Sato, Takayuki and Maeda, Takeshi and Onishi, Tatsuhito and Ueda, Yasunori},
  title = {Intraprocedural Yield Estimation Using Interim Product CD34 + Concentration Improves the Prediction Accuracy in Allogeneic Peripheral Blood Stem Cell Harvest},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {960--970},
  doi = {10.1002/1744-9987.70189}
}
Kostenlos starten →